Impaired expression of glycoproteins on resting and stimulated platelets in uraemic patients. 2003

Valérie Moal, and Philippe Brunet, and Laetitia Dou, and Sophie Morange, and José Sampol, and Yvon Berland
Service de Néphrologie et d'Hémodialyse, Hôpital de la Conception, Marseille Cedex, France.

BACKGROUND The increased bleeding tendency of chronic renal failure (CRF) patients has been attributed to platelet dysfunction. However, reports on various platelet functions in uraemic patients have been conflicting. The present study sought to analyse platelet function by examining their surface glycoproteins in well-identified populations of CRF patients. METHODS Three groups were studied: 22 chronic haemodialysis (HD) patients, 25 conservatively treated patients with CRF and 30 controls. Bleeding tendency was assessed by measuring bleeding time and by recording current haemorrhagic symptoms. We measured the fibrinogen receptor GPIIbIIIa, the von Willebrand receptor GPIb, and P-selectin levels on the platelet surface using flow cytometry. RESULTS Forty percent of CRF and 45% of HD patients had bleeding. The bleeding time was similar in the HD and CRF groups, but was longer in both groups than in controls. In resting platelets, GPIb expression was lower in CRF patients than in controls. In stimulated platelets (i) GPIb expression was higher in HD patients than in both controls and CRF patients; and (ii) GPIIbIIIa and P-selectin expression were lower in CRF and HD patients than in controls. CONCLUSIONS These findings indicate that uraemic platelets are hyporesponsive to stimulation.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D001778 Blood Coagulation Disorders Hemorrhagic and thrombotic disorders that occur as a consequence of abnormalities in blood coagulation due to a variety of factors such as COAGULATION PROTEIN DISORDERS; BLOOD PLATELET DISORDERS; BLOOD PROTEIN DISORDERS or nutritional conditions. Coagulation Disorders, Blood,Disorders, Blood Coagulation,Blood Coagulation Disorder,Coagulation Disorder, Blood,Disorder, Blood Coagulation
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Valérie Moal, and Philippe Brunet, and Laetitia Dou, and Sophie Morange, and José Sampol, and Yvon Berland
May 1984, The American journal of pathology,
Valérie Moal, and Philippe Brunet, and Laetitia Dou, and Sophie Morange, and José Sampol, and Yvon Berland
October 1999, Pediatric research,
Valérie Moal, and Philippe Brunet, and Laetitia Dou, and Sophie Morange, and José Sampol, and Yvon Berland
August 1990, Thrombosis and haemostasis,
Valérie Moal, and Philippe Brunet, and Laetitia Dou, and Sophie Morange, and José Sampol, and Yvon Berland
November 1987, Blood,
Valérie Moal, and Philippe Brunet, and Laetitia Dou, and Sophie Morange, and José Sampol, and Yvon Berland
August 1993, Journal of biochemistry,
Valérie Moal, and Philippe Brunet, and Laetitia Dou, and Sophie Morange, and José Sampol, and Yvon Berland
November 1992, Cellular signalling,
Valérie Moal, and Philippe Brunet, and Laetitia Dou, and Sophie Morange, and José Sampol, and Yvon Berland
May 1986, The Journal of biological chemistry,
Valérie Moal, and Philippe Brunet, and Laetitia Dou, and Sophie Morange, and José Sampol, and Yvon Berland
November 1986, Biochimica et biophysica acta,
Valérie Moal, and Philippe Brunet, and Laetitia Dou, and Sophie Morange, and José Sampol, and Yvon Berland
January 2005, Artificial cells, blood substitutes, and immobilization biotechnology,
Valérie Moal, and Philippe Brunet, and Laetitia Dou, and Sophie Morange, and José Sampol, and Yvon Berland
January 1972, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
Copied contents to your clipboard!